1-phenyl-3,3-dimethyltriazene has been researched along with Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 5 (100.00) | 2.80 |
Authors | Studies |
---|---|
Falk-Mahapatra, R; Gollnick, SO | 1 |
Chen, Z; Feng, L; Ji, W; Jiang, G; Li, C; Liu, L; Tang, BZ; Wang, J; Wang, Z; Yu, J; Zhang, P | 1 |
Guo, H; Liu, B; Liu, E; Liu, F; Lu, L; Sun, G; Sun, W; Wei, S | 1 |
Chen, L; Fu, L; Hou, J; Huang, Y; Sun, M; Wang, L; Wang, X | 1 |
Chen, K; Liu, Y; Shi, M; Shi, P; Sun, X; Yang, Y; Yu, J; Zhang, S | 1 |
5 other study(ies) available for 1-phenyl-3,3-dimethyltriazene and Neoplasms
Article | Year |
---|---|
Photodynamic Therapy-Induced Cyclooxygenase 2 Expression in Tumor-Draining Lymph Nodes Regulates B-Cell Expression of Interleukin 17 and Neutrophil Infiltration.
Topics: Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Humans; Interleukin-17; Lymph Nodes; Neoplasms; Neutrophil Infiltration; Nuclear Receptor Subfamily 1, Group F, Member 3; Photochemotherapy; Triazenes | 2022 |
Acceptor Planarization and Donor Rotation: A Facile Strategy for Realizing Synergistic Cancer Phototherapy
Topics: Humans; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Phototherapy; Triazenes | 2022 |
Dual-responsive nano-prodrug micelles for MRI-guided tumor PDT and immune synergistic therapy.
Topics: Humans; Magnetic Resonance Imaging; Micelles; Neoplasms; Photochemotherapy; Prodrugs; Triazenes; Tumor Microenvironment | 2022 |
A Raman/fluorescence dual-modal imaging guided synergistic photothermal and photodynamic therapy nanoplatform for precision cancer theranostics.
Topics: Fluorescent Dyes; Gold; Humans; Metal Nanoparticles; Neoplasms; Photochemotherapy; Precision Medicine | 2022 |
CeO
Topics: Cell Line, Tumor; Humans; Hyaluronic Acid; Hydrogen Peroxide; Metal-Organic Frameworks; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Triazenes | 2022 |